50 cancer patients will take part in the first phase of clinical tests of the Russian cancer vaccine. According to Mash, the acceptance of applications for participation is closed – there were more than 6 thousand of them.
At the Moscow Scientific Research Institute named after Herzen, they told us: the commission has already begun the selection of participants, preference will be given to cancer patients, which have already passed through treatment-chemothames and other therapy, as well as surgical intervention. With adulthood sufficient for the experiment. The first stage of the program will last until the end of 2025, all this time the test participants will be under the constant monitoring of doctors – to check the drug for safety and select the correct dosage.
More people are promised to call the second phase – to study the effects of oncaccines on different types of cancer. It is assumed that at the final stage of tests the drug will be combined with other treatment methods. But they warn: in the near future, a magic tablet from cancer should not be expected. The vaccine tests will take at least 9 years.
❗️Subscribe to Mash
